NEU neuren pharmaceuticals limited

Ann: 2022 Annual Report to shareholders, page-2

  1. 1,476 Posts.
    lightbulb Created with Sketch. 373
    Such good reading, professional report and reads extremely upbeat.

    My biggest takeaway is Neuren's confidence in the ongoing trials moving to Phase 3 - IMO if they are preparing al;ready for the next phase it demonstrates high confidence (which is understandable given the mouse trial results).

    As good as the past 3 months has been, im excited for the next 6 months !
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.03
Change
0.175(1.36%)
Mkt cap ! $1.626B
Open High Low Value Volume
$13.15 $13.37 $12.92 $5.886M 448.9K

Buyers (Bids)

No. Vol. Price($)
15 401 $13.02
 

Sellers (Offers)

Price($) Vol. No.
$13.03 503 9
View Market Depth
Last trade - 15.20pm 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.